Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties.

Adv Neurol

Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel.

Published: September 1999

Download full-text PDF

Source

Publication Analysis

Top Keywords

apomorphine dopamine
4
dopamine receptor
4
receptor agonist
4
agonist remarkable
4
remarkable antioxidant
4
antioxidant cytoprotective
4
cytoprotective properties
4
apomorphine
1
receptor
1
agonist
1

Similar Publications

Dopaminergic system gains importance in homeostatic sleep regulation, but the role of different dopamine receptors is not well-defined. 72 h rat electrocorticogram and sleep recordings were made after single application of dopaminergic drugs in clinical use or at least underwent clinical trials. The non-selective agonist apomorphine evoked short pharmacological sleep deprivation with intense wakefulness followed by pronounced sleep rebound.

View Article and Find Full Text PDF

The aim of the present study was to investigate the role of ovarian hormones on dopaminergic regulation of prepulse inhibition (PPI), a measure of sensorimotor gating deficient in schizophrenia and other psychiatric illnesses. Either in adulthood (11 weeks of age) or adolescence (5 weeks of age), female mice underwent ovariectomy (OVX) and were implanted with 17β-estradiol, progesterone, or a combination of these hormones. All mice were tested in adulthood for the acute effect of the dopamine receptor agonist, apomorphine, on PPI.

View Article and Find Full Text PDF

Background: In experimental and clinical studies of pharmacological treatments for Alzheimer's disease (AD), the electroencephalogram (EEG) frequency spectrum approach has demonstrated its efficacy in determining the characteristics of pathological changes in the functioning of different cerebral structures, interconnections between them, and disturbances in the brain neurotransmitter systems. The main results have been obtained in frames of traditionally used so-called "classical" EEG frequency bands: delta, theta, alpha, and beta.

Objective: This unified approach simplifies comparing data from different studies but loses the dynamic peculiarities of the effects because of their time-dependent transition through the borders of the "classical" bands.

View Article and Find Full Text PDF

The progressive decline of dopaminergic neurons in Parkinson's disease (PD) has been linked to an imbalance in energy and the failure of mitochondrial function. AMP-activated protein kinase (AMPK), the major intracellular energy sensor, regulates energy balance, and damage to nigral dopaminergic neurons induced by 6-hydroxydopamine (6-OHDA) is exacerbated in the absence of AMPK activity. This study aimed to examine the potential therapeutic advantages of AdipoRon, an AMPK activator, on motor function and mitochondrial homeostasis in a 6-OHDA-induced PD model.

View Article and Find Full Text PDF
Article Synopsis
  • * Data was collected from 37 patients treated between 2011 and 2022, highlighting that half started nocturnal treatment for motor issues, while others suffered from various non-motor symptoms.
  • * The findings show 54% of patients maintained treatment by the end, with some discontinuing due to adverse reactions, indicating the treatment's overall effectiveness and safety despite some challenges.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!